- Home
- CGEM vs BMBL Comparison
CGEM vs BMBL Comparison
Compare CGEM & BMBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- BMBL
- Stock Information
- Founded
- CGEM 2016
- BMBL 2014
- Country
- CGEM United States
- BMBL United States
- Employees
- CGEM N/A
- BMBL N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- BMBL Computer Software: Prepackaged Software
- Sector
- CGEM Health Care
- BMBL Technology
- Exchange
- CGEM Nasdaq
- BMBL Nasdaq
- Market Cap
- CGEM 482.7M
- BMBL 446.5M
- IPO Year
- CGEM 2021
- BMBL 2021
- Fundamental
- Price
- CGEM $8.19
- BMBL $6.36
- Analyst Decision
- CGEM Strong Buy
- BMBL Hold
- Analyst Count
- CGEM 7
- BMBL 14
- Target Price
- CGEM $26.57
- BMBL $6.65
- AVG Volume (30 Days)
- CGEM 364.2K
- BMBL 4.5M
- Earning Date
- CGEM 08-07-2025
- BMBL 08-06-2025
- Dividend Yield
- CGEM N/A
- BMBL N/A
- EPS Growth
- CGEM N/A
- BMBL N/A
- EPS
- CGEM N/A
- BMBL N/A
- Revenue
- CGEM N/A
- BMBL $1,030,583,000.00
- Revenue This Year
- CGEM N/A
- BMBL N/A
- Revenue Next Year
- CGEM N/A
- BMBL N/A
- P/E Ratio
- CGEM N/A
- BMBL N/A
- Revenue Growth
- CGEM N/A
- BMBL N/A
- 52 Week Low
- CGEM $6.85
- BMBL $3.55
- 52 Week High
- CGEM $19.89
- BMBL $9.22
- Technical
- Relative Strength Index (RSI)
- CGEM 56.95
- BMBL 43.80
- Support Level
- CGEM $6.89
- BMBL $6.26
- Resistance Level
- CGEM $8.08
- BMBL $6.58
- Average True Range (ATR)
- CGEM 0.40
- BMBL 0.45
- MACD
- CGEM 0.05
- BMBL -0.09
- Stochastic Oscillator
- CGEM 92.20
- BMBL 27.17
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company Operates in USA and also Internationally such as United Kingdom, Czech Republic, and others with maximum of revenue from Other Countries.